These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season. Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, Caperig-Dapat I, Oguma T, Shabana II, Saito T, Suzuki H, Japanese Influenza Collaborative Study Group. J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344 [Abstract] [Full Text] [Related]
4. Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation. Saito R, Sato I, Suzuki Y, Baranovich T, Matsuda R, Ishitani N, Dapat C, Dapat IC, Zaraket H, Oguma T, Suzuki H. Pediatr Infect Dis J; 2010 Oct; 29(10):898-904. PubMed ID: 20442686 [Abstract] [Full Text] [Related]
8. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons. Kawai N, Ikematsu H, Hirotsu N, Maeda T, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Matsuura S, Nishimura M, Iwaki N, Kashiwagi S. Clin Infect Dis; 2009 Dec 15; 49(12):1828-35. PubMed ID: 19911968 [Abstract] [Full Text] [Related]
9. Influenza virus susceptibility and resistance to oseltamivir. Aoki FY, Boivin G, Roberts N. Antivir Ther; 2007 Dec 15; 12(4 Pt B):603-16. PubMed ID: 17944268 [Abstract] [Full Text] [Related]
10. Outcomes and Susceptibility to Neuraminidase Inhibitors in Individuals Infected With Different Influenza B Lineages: The Influenza Resistance Information Study. van der Vries E, Ip DK, Cowling BJ, Zhang JD, Tong X, Wojtowicz K, Schutten M, Boucher CA. J Infect Dis; 2016 Jan 15; 213(2):183-90. PubMed ID: 26160744 [Abstract] [Full Text] [Related]
13. Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Whitley RJ, Boucher CA, Lina B, Nguyen-Van-Tam JS, Osterhaus A, Schutten M, Monto AS. Clin Infect Dis; 2013 May 15; 56(9):1197-205. PubMed ID: 23307766 [Abstract] [Full Text] [Related]
16. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children. Sugaya N, Tamura D, Yamazaki M, Ichikawa M, Kawakami C, Kawaoka Y, Mitamura K. Clin Infect Dis; 2008 Aug 01; 47(3):339-45. PubMed ID: 18582202 [Abstract] [Full Text] [Related]
17. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections. Escuret V, Cornu C, Boutitie F, Enouf V, Mosnier A, Bouscambert-Duchamp M, Gaillard S, Duval X, Blanchon T, Leport C, Gueyffier F, Van Der Werf S, Lina B. Antiviral Res; 2012 Nov 01; 96(2):130-7. PubMed ID: 22909899 [Abstract] [Full Text] [Related]
20. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. Kawai N, Ikematsu H, Iwaki N, Kawashima T, Maeda T, Mitsuoka S, Kondou K, Satoh I, Miyachi K, Yamaga S, Shigematsu T, Hirotsu N, Kashiwagi S. J Infect; 2007 Sep 01; 55(3):267-72. PubMed ID: 17604839 [Abstract] [Full Text] [Related] Page: [Next] [New Search]